Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
about
Rapid, Multiplexed Characterization of Shiga Toxin-Producing Escherichia coli (STEC) Isolates Using Suspension Array TechnologyEscherichia coli and Sudden Infant Death SyndromeGut inflammation and immunity: what is the role of the human gut virome?The Crystal Structure of Shiga Toxin Type 2 with Bound Disaccharide Guides the Design of a Heterobifunctional Toxin InhibitorDiarrheagenic Escherichia coli.Structural insight into host recognition by aggregative adherence fimbriae of enteroaggregative Escherichia coliStudy of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11.Enteroaggregative Escherichia coli quantification in children stool samples using quantitative PCRPrevalence of enteroaggregative Escherichia coli and its virulence-related genes in a case-control study among children from north-eastern Brazil.Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada.[Management of patients with EHEC/HUS. Lessons and perspectives from clinical infectious disease specialists].Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in GermanyProphage induction is enhanced and required for renal disease and lethality in an EHEC mouse model.Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsEscherichia coli O104:H4 outbreak in Germany--clarification of the origin of the epidemic.Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.Cyclic-di-GMP signalling and biofilm-related properties of the Shiga toxin-producing 2011 German outbreak Escherichia coli O104:H4.Enteroaggregative Escherichia coli, a heterogenous, underestimated and under-diagnosed E. coli pathotype in IranComparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7.Characterization of two UDP-Gal:GalNAc-diphosphate-lipid β1,3-galactosyltransferases WbwC from Escherichia coli serotypes O104 and O5.Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivativesSequences of two related multiple antibiotic resistance virulence plasmids sharing a unique IS26-related molecular signature isolated from different Escherichia coli pathotypes from different hosts.Drainage systems, an occluded source of sanitation related outbreaks.Bacteriophages: an underestimated role in human and animal health?Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers.Waterborne pathogens: detection methods and challenges.An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coliVirulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestineMobile effector proteins on phage genomes.Genome sequence of Escherichia coli NCCP15653, a group D strain isolated from a diarrhea patient.Heterogeneity in Induction Level, Infection Ability, and Morphology of Shiga Toxin-Encoding Phages (Stx Phages) from Dairy and Human Shiga Toxin-Producing Escherichia coli O26:H11 Isolates.Mobile elements, zoonotic pathogens and commensal bacteria: conduits for the delivery of resistance genes into humans, production animals and soil microbiota.Adherence of non-O157 Shiga toxin-producing Escherichia coli to bovine recto-anal junction squamous epithelial cells appears to be mediated by mechanisms distinct from those used by O157.On the exoneration of Dr. William H. Stewart: debunking an urban legend.Aflatoxin, fumonisin and Shiga toxin-producing Escherichia coli infections in calves and the effectiveness of Celmanax®/Dairyman's Choice™ applications to eliminate morbidity and mortality losses.Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.Shigatoxin encoding Bacteriophage ϕ24B modulates bacterial metabolism to raise antimicrobial tolerance.The arable ecosystem as battleground for emergence of new human pathogens.Bacterial toxin inhibitors based on multivalent scaffolds.
P2860
Q26744691-E32154C4-9780-478D-A10E-86CFD3FC88F5Q26801961-14D473AC-5B11-42D7-89E2-66CEDD596E08Q26822006-8EAF7B20-1226-4A86-A303-5753F044E776Q27680604-3801A95C-756B-471F-8177-775211A8AD84Q28078385-DFE89353-6537-42FC-9E50-89F46B02D0DBQ28543077-2636898D-4581-4600-9397-930A9244FB6CQ30400998-055D322A-F811-4400-80B5-BE00ECA09CECQ30412073-6DB69548-1F57-423C-A8FE-508DA758A009Q30413400-AB40F281-D653-4915-B25D-FB59C3AE969DQ33404520-6928C9C3-FC80-40EA-9B31-0976362FD707Q33405034-13C5CF78-781C-44A5-9697-9B4D0FCB834CQ33405088-DD3EC8A3-AC06-4D5E-A237-F7788A163BCFQ33406825-3D31962D-B76B-432D-ABBC-F6627AC47BC1Q33407861-1CED5F31-3CF5-4622-995C-EDF510B9B182Q33414627-4F1E6E68-F0EF-4447-9A3E-A831F5BA3AA5Q33415691-C5CC15E5-9ED7-4B83-97E0-0BE13E1D7832Q33418487-B79CDABD-A304-407E-AC06-2B433FE9BFF3Q33596560-E99F06BA-45C0-4B9C-98CC-CB0F3AE1B01BQ33730844-C8142A90-C887-4721-A385-0D829832D464Q34056721-F81A5624-3F26-4BF9-A9D4-A3D8CCD9058DQ34623924-B0CA8676-0519-4FA7-8965-90F26E8AEBD6Q35041070-857613A3-D0BC-4685-ABF3-5CAAE263FEE6Q35125735-217BFF3D-3F03-4F2B-ADBC-9799E9FEA0CAQ35148271-8010C02E-B22A-4E6B-9EC9-A4ACC6F6FC32Q35757493-BBBE91BC-C5B6-4858-B75F-4DF79E341B1DQ35824395-B0C03D05-4B83-4F45-86BD-10E4D0952312Q35961023-77C08895-8B47-45B7-8155-E6989B6C99A4Q36396212-4610B102-9F4F-457E-987C-C41A01255EE4Q36489643-6C497DFA-43E4-41A0-8AFA-23D48D07233EQ36611851-20898C3C-3281-44C7-9704-F072E4C2DFE9Q36728123-E14BA745-901D-416A-B120-5E687B73F3F7Q36804038-A16B82E2-4A65-4D27-89AE-13EF314FABEFQ36865822-CBDF5646-3806-41DB-AB0C-6C10A777DC6DQ36998858-FB4B3496-FB9D-4EC1-84A7-8FE26292575DQ37269935-51838CB7-6AB6-4C2B-9B49-02FD457A53F1Q37428539-824D2AA8-B03C-4F9D-9BA7-6B5DB1A4932EQ37589201-5864E809-41E8-496F-88E3-105431ED5B96Q37595385-2AF383B6-CE2C-4293-B366-4B469431068CQ37650562-92B33BE4-6605-45B6-BBF4-354FE63413EAQ38069445-85F8B334-0F5C-45AA-BA98-7971AC97C16E
P2860
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@ast
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@en
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@nl
type
label
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@ast
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@en
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@nl
prefLabel
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@ast
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@en
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@nl
P2093
P2860
P3181
P356
P1476
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology
@en
P2093
Bernd Appel
Harald Brüssow
Stefan Hertwig
P2860
P304
P3181
P356
10.1128/AEM.00217-12
P407
P577
2012-04-13T00:00:00Z